FTC, Valeant See Eye-To-Eye On Paragon Divestiture
The U.S. Federal Trade Commission signed off on a settlement with Valeant Pharmaceuticals International Inc. over its 2015 purchase of a contact lens manufacturer, finding on Wednesday that the Canadian pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article